Protara Therapeutics, Inc. Common Stock TARA
$3.85
+0.92%
at last close
Financials (TTM)
- Revenue
- $3.14 million
- Net Income
- $-70,015,000
- Net Margin
- -2232.62%
- Return on Equity
- -43.40%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 1.40
- Price / Sales
- 71.98
Over the trailing twelve months, Protara Therapeutics, Inc. Common Stock generated revenue of $3.14 million and net income of $-70,015,000, a net margin of -2232.62%.
At the last closing price of $3.85, TARA trades at 71.98 times sales, with a market capitalization of $225.74 million.
Key Stats
- Last Close
- $3.85
- Market Cap
- $225.74 million
- 52-Week Range
- $2.97 – $7.82
- Average Volume
- 379K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.